You have not yet given permission to place the required cookies. Accept the required cookies to view this content.
1104
Expert views
October 29, 2021
SCOR has created "Vitae Breast Cancer", a relapse risk calculator
document
October 27, 2021 — 06:38
SCOR records a net income of EUR 339 million, demonstrating its shock-absorbing capacity, and launches a EUR 200 million share buy-back program
Expert views
October 22, 2021
SCOR is revaluating the way we consider risk
Expert views
October 21, 2021
Most of us will need long-term care at the end of our lives, yet it is one of the largest uninsured risks facing the elderly.
Expert views
October 7, 2021
The 8th annual Global Consumer Study by ReMark, a SCOR Group company, sheds light on what consumers worldwide feel about health, AI, data privacy, and more.
Expert views
October 1, 2021
Underwriting must accommodate the foundational changes entering the industry, like it or not. For some, this presents welcome opportunity; but for others, it represents the discomfort and threat of change.
Expert views
October 1, 2021
The benefits of accelerated underwriting to applicants, direct companies and reinsurers are clear – faster, less intrusive, cost-effective underwriting with minimal mortality slippage, especially in programs that make